Identificador persistente para citar o vincular este elemento: http://hdl.handle.net/10553/46789
Campo DC Valoridioma
dc.contributor.authorSánchez-Hernández, Rosa M.en_US
dc.contributor.authorGarcía-Cantón, Césaren_US
dc.contributor.authorLorenzo, Dionisio L.en_US
dc.contributor.authorQuevedo, Virginiaen_US
dc.contributor.authorBosch, Elviraen_US
dc.contributor.authorLópez-Ríos, Lauraen_US
dc.contributor.authorRiaño, Martaen_US
dc.contributor.authorBoronat, Mauroen_US
dc.date.accessioned2018-11-23T08:12:28Z-
dc.date.available2018-11-23T08:12:28Z-
dc.date.issued2015en_US
dc.identifier.issn0301-0430en_US
dc.identifier.urihttp://hdl.handle.net/10553/46789-
dc.description.abstractAims: Vitamin D deficiency is highly prevalent in subjects with advanced chronic kidney disease (CKD), but diabetes, the most common cause of CKD, has also been linked to low levels of serum 25-hydroxyvitamin D [25(OH) D]. We compare vitamin D status between subjects with type 2 diabetes-related advanced CKD and subjects with either advanced CKD without diabetes or type 2 diabetes without advanced CKD. Methods: Subjects were patients with advanced CKD (estimated glomerular filtration rate (eGFR) < 30 mL/min/1.73 m(2)) from February 2011 to November 2013 (113 with diabetes-related CKD and 80 without diabetes) and 61 patients with long-lasting type 2 diabetes without advanced CKD, simultaneously enrolled from our center. Participants fulfilled a survey questionnaire and underwent physical examination, blood samples, and 24-h urine collection. Kidney disease was assessed using eGFR and 24-h urinary protein excretion. Serum 25(OH) D was measured by chemiluminescence immunoassay. Results: The prevalence of vitamin D deficiency (25(OH) D < 20 ng/mL) was 70.8% in subjects with diabetes-related CKD, 38.8% in subjects with non-diabetic CKD and 41% in subjects with diabetes without advanced CKD. Adjusted means (95% confidence interval (CI)) of 25(OH) D in participants with diabetes-related CKD, in nondiabetic participants with CKD, and in participants with diabetes without advanced CKD were, respectively, 17.5 (14.2 - 20.7), 23.6 (19.4 - 27.8), and 23.5 (16.8 - 30.3) ng/mL (p = 0.023). Conclusions: Low vitamin D status is characteristically associated with advanced diabetic nephropathy. This relationship is not entirely attributable to the individual effects of CKD or long-lasting diabetes.en_US
dc.languageengen_US
dc.relation.ispartofClinical Nephrologyen_US
dc.sourceClinical Nephrology[ISSN 0301-0430],v. 83, p. 218-224en_US
dc.subject32 Ciencias médicasen_US
dc.subject320506 Nefrologíaen_US
dc.subject.other25-Hydroxyvitamin D Levelsen_US
dc.subject.other3Rd National-Healthen_US
dc.subject.otherEnhanced Excretionen_US
dc.subject.otherAssociationen_US
dc.subject.otherMegalinen_US
dc.titleThe specific relationship between vitamin D deficiency and diabetic nephropathy among patients with advanced chronic kidney disease: A cross-sectional study in Gran Canaria, Spainen_US
dc.typeinfo:eu-repo/semantics/Articleen_US
dc.typeArticleen_US
dc.identifier.doi10.5414/CN108446en_US
dc.identifier.scopus84933043064-
dc.identifier.isi000352238000003-
dc.contributor.authorscopusid57203232814-
dc.contributor.authorscopusid6603127359-
dc.contributor.authorscopusid55967938300-
dc.contributor.authorscopusid57188624099-
dc.contributor.authorscopusid36027905600-
dc.contributor.authorscopusid33068166900-
dc.contributor.authorscopusid37067926100-
dc.contributor.authorscopusid7003952293-
dc.description.lastpage224en_US
dc.description.firstpage218en_US
dc.relation.volume83en_US
dc.investigacionCiencias de la Saluden_US
dc.type2Artículoen_US
dc.contributor.daisngid3858758-
dc.contributor.daisngid1915819-
dc.contributor.daisngid30519221-
dc.contributor.daisngid5112593-
dc.contributor.daisngid1780664-
dc.contributor.daisngid1964185-
dc.contributor.daisngid5257474-
dc.contributor.daisngid673494-
dc.description.numberofpages7en_US
dc.utils.revisionen_US
dc.contributor.wosstandardWOS:Sanchez-Hernandez, RM-
dc.contributor.wosstandardWOS:Garcia-Canton, C-
dc.contributor.wosstandardWOS:Lorenzo, DL-
dc.contributor.wosstandardWOS:Quevedo, V-
dc.contributor.wosstandardWOS:Bosch, E-
dc.contributor.wosstandardWOS:Lopez-Rios, L-
dc.contributor.wosstandardWOS:Riano, M-
dc.contributor.wosstandardWOS:Boronat, M-
dc.date.coverdateAbril 2015en_US
dc.identifier.ulpgcen_US
dc.contributor.buulpgcBU-MEDen_US
dc.description.sjr0,519
dc.description.jcr1,065
dc.description.sjrqQ3
dc.description.jcrqQ4
dc.description.scieSCIE
item.grantfulltextnone-
item.fulltextSin texto completo-
crisitem.author.deptDepartamento de Ciencias Médicas y Quirúrgicas-
crisitem.author.deptGIR IUIBS: Diabetes y endocrinología aplicada-
crisitem.author.deptIU de Investigaciones Biomédicas y Sanitarias-
crisitem.author.deptDepartamento de Ciencias Médicas y Quirúrgicas-
crisitem.author.orcid0000-0002-5988-8222-
crisitem.author.orcid0000-0001-8535-8543-
crisitem.author.parentorgIU de Investigaciones Biomédicas y Sanitarias-
crisitem.author.fullNameGarcía Cantón, César-
crisitem.author.fullNameLorenzo Villegas, Dionisio Lorenzo-
crisitem.author.fullNameBoronat Cortés, Mauro-
Colección:Artículos
Vista resumida

Citas SCOPUSTM   

20
actualizado el 14-abr-2024

Citas de WEB OF SCIENCETM
Citations

22
actualizado el 25-feb-2024

Visitas

77
actualizado el 20-ene-2024

Google ScholarTM

Verifica

Altmetric


Comparte



Exporta metadatos



Los elementos en ULPGC accedaCRIS están protegidos por derechos de autor con todos los derechos reservados, a menos que se indique lo contrario.